Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Research Coverage on Small and Micro-Cap Companies

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Equity Bottom-Up

Revelation Biosciences  / Equity Bottom-Up

<ul><li>Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of phosphorylated hexaacyl disaccharide (PHAD) and its effect on the innate immune system.</li><li> The company announced data from its Phase 1 clinical study of its Gemini treatment.</li><li>These results were extremely positive and represent a major step forward for Revelation.</li></ul>

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of phosphorylated hexaacyl disaccharide (PHAD) and its effect on the innate immune system. The company announced data from its Phase 1 clinical study of its Gemini treatment.These results were extremely positive and represent a major step forward for Revelation.

REVB:  Positive Results Set Stage for Next Step

<ul><li>Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of phosphorylated hexaacyl disaccharide (PHAD) and its effect on the innate immune system.</li><li> The company announced 1Q2024 results and we remind investors that the company has begun Phase I trials on its Gemini project and has funding needs met through 2024, which is extremely positive for a clinical stage company.</li></ul>

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of phosphorylated hexaacyl disaccharide (PHAD) and its effect on the innate immune system. The company announced 1Q2024 results and we remind investors that the company has begun Phase I trials on its Gemini project and has funding needs met through 2024, which is extremely positive for a clinical stage company.

REVB:  1Q Results Reveal Solid Cash Balance

United States

Bellicum Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company focuses on discovering and developing novel cellular immunotherapies for cancer, tumors, and blood diseases. Bellicum Pharmaceuticals serves patients in the United States.

Navidea Biopharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of precision radiopharmaceutical diagnostics for diseases such as cancer.

Aravive, Inc. operates as a biotechnology company. The Company develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders. Aravive serves patients in the United States.

Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It offer tests for disorders in cardiovascular, hereditary cancer, neurology, pediatrics, and other rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.

Salarius Pharmaceuticals Inc is a clinical-stage oncology company. The Company specializes in targeting the epigenetic causes of cancers and developing treatments for patients. Salarius Pharmaceuticals serves patients and customers in the State of Texas.

Trevena, Inc. develops pharmaceutical products. The Company offers discovery and development of agents targeting G-protein coupled receptors and therapies and drugs that treat acute heart failure, acute chronic pain, and depression. Trevena serves customers throughout the United States.

Sorrento Therapeutics, Inc. is a biopharmaceutical company. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic, and infectious diseases.

Otonomy, Inc. operates as a clinical stage biopharmaceutical company. The Company develops therapeutics for treatment of inner and middle ear disorders.

Infinity Pharmaceuticals, Inc. researches and develops cancer drugs.  The Company uses small molecule drug technologies in the development of its products.

Organovo Holdings, Inc. operates as a biology company. The Company focuses on bio-printing technology and creating tissues for research and medical applications.

Bionomics Limited operates as a biotechnology company, which specializes in the genetics field.  The Company, which is affiliated with a number of research institutions, seeks to develop a variety of genomic, genetic, molecular and cell biology techniques, which they believe will help demonstrate the onset and progression of diseases like epilepsy and breast cancer.

Bioxyne  Limited operates as a biotechnology company.  The Company specializes in the research, development and commercialization of diseases related to chronic obstructive pulmonary disease(COPD).

DorsaVi Ltd. develops and sells wireless sensor movement monitoring systems. The Company's technology is used by the to monitor workplace and sports related injury and pain.

Regeneus Ltd is a regenerative medicine company focused on using the regenerative capacities of adipose-derived cells to develop innovative cell therapies for humans and animals.

Hybrigenics S.A. is a biotechnology and pharmaceutical company. The Company develops therapeutics against cancer as well as develops platforms to identify, validate and inhibit protein interactions.

Neovacs is a biotechnology company.  The Company researches immunotherapy applications for autoimmune diseases, inflammatory diseases such as rheumatoid arthritis, cancer and other conditions.

PAION AG, together with its subsidiaries, operates as a biopharmaceutical company focusing on the clinical development of drug candidates for diseases or interventions with a substantial unmet medical need.

Quantum Genomics SAS is a global biotechnology company. The Company researches and develops treaments for human diseases, including cardiovascular diseases, neurology and metabolic related diseases.

Oxurion NV is a biopharmaceutical company focused on developing treatments for diabetic eye disease. The Company's R&D pipeline of disease modifying drug candidates focuses on diabetic retinopathy (DR) and diabetic macular edema (DME). Oxurion has disease-modifying molecules in its pipeline addressing all segments of the DR and DME market.

Targovax AS develops biopharmaceutics. The Company specializes in creation of therapeutic vaccines for various types of cancer. Targovax serves the healthcare sector.

Revelation Biosciences Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing therapeutics and diagnostics for viral infections by harnessing the power of the innate immune system. Revelation Biosciences serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Revelation Biosciences (REVB US)

REVB: Positive Results Set Stage for Next Step

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of...

Zacks Small Cap Research

REVB: 1Q Results Reveal Solid Cash Balance

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of...

Zacks Small Cap Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)